MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata in a patient with anti-Ma associated encephalitis.

    C. Espinoza-Vinces, A. Horrillo, R. Villino, A. Solis, P. Domínguez, J. Arbizu, MR. Luquin, E. Urrestarazu, I. Avilés-Olmos (Pamplona, Spain)

    Objective: To describe a case of a patient with narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata, who presented with anti-Ma encephalitis. Background:…
  • 2023 International Congress

    Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

    T. Danaila, E. Metereau (Bron, France)

    Objective: Better understand the social interactions by assessing the effect of oral levodopa on the social cognition abilities in fluctuating PD patients without significant cognitive disorder.…
  • 2023 International Congress

    Jaw opening myoclonus in Subacute Sclerosing Panencephalitis: A new phenotypic observation which may be a diagnostic clue

    D. Garg, S. Sharma (New Delhi, India)

    Objective: We aimed to study the frequency of jaw myoclonus in subacute sclerosing panencephalitis (SSPE). Background: SSPE is a rare disorder due to mutant measles…
  • 2023 International Congress

    Sex differences for off episodes in Parkinson’s disease

    A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)

    Objective: To determine the sex differences for the frequency, duration, and impact of off episodes in Parkinson’s disease (PD). Background: Dopamine replacement therapy through oral…
  • 2023 International Congress

    Management of Sigmoid Volvulus in Parkinson’s patients presenting to Royal Berkshire Hospital, Reading ,UK.

    M. Khwaja, S. Alam, A. Chatterjee, E. Castaneda-Cicedo (Reading, United Kingdom)

    Objective: To evaluate acute management of volvulus in Parkinson’s Background: Constipation affects upto 50% of patients with Parkinson's and sigmoid volvulus is an under recognized…
  • 2023 International Congress

    How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial

    R. Hauser, G. Banisadr, S. Fisher, H. Visser, R. D'Souza (Tampa, USA)

    Objective: To provide guidance on dosing of IPX203 based on clinical trial experience. Background: IPX203 is an extended-release, oral carbidopa-levodopa (CD-LD) formulation designed to rapidly…
  • 2023 International Congress

    Neurologic Music Therapy (NMT) and Non-Invasive Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome (CBS)

    K. Kang, A. Pantelyat (Baltimore, USA)

    Objective: To investigate if NMT with or without non-invasive brain stimulation can improve upper limb performance in patients with corticobasal syndrome Background: Previous research suggests…
  • 2023 International Congress

    Does beta band activity correlate with electrode location within the STN in postoperative processed images?

    M. Ruiz-Lopez, B. Tijero, T. Fernandez, G. Bilbao, JC. Gomez-Esteban, E. Ruiz Degopegui (Bilbao, Spain)

    Objective: To identify the best tool for guidance in an initial programming of deep brain stimulation (DBS).To explore the potential correlation between postoperative images created…
  • 2023 International Congress

    Identifying delirium in Parkinson’s: evaluation of existing tools and measures

    R. Lawson, S. Richardson, F. Gerakios, G. Bate (Newcastle upon Tyne, United Kingdom)

    Objective: To evaluate the diagnostic accuracy of tools to identify delirium in inpatients with Parkinson’s disease (PD). Background: Delirium is a serious acute state of…
  • 2023 International Congress

    D-penicillamine induced myasthenia gravis – the possible complication of Wilson’s disease treatment.

    A. Antos, T. Litwin, J. Bembenek, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)

    Objective: D-penicillamine (DPA) belongs to the most frequently used drugs in Wilson’s disease (WD) treatment. Despite the effectiveness in WD treatment, DPA could be involved in many…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley